Buspirone 5 mg BID Does Not Require Tapering When Discontinued
Buspirone at 5 mg twice daily can be stopped abruptly without tapering, as it does not cause physical dependence or withdrawal symptoms. This is fundamentally different from benzodiazepines and other anxiolytics that require gradual dose reduction.
Key Evidence Supporting Abrupt Discontinuation
The most definitive evidence comes from a large multicenter safety trial where buspirone was abruptly discontinued after more than 6 months of continuous therapy, and assessments yielded no evidence of a withdrawal syndrome or unusual events 1. This study included 424 patients treated for 6 months and 264 patients who completed a full year of treatment, providing robust safety data for long-term use and discontinuation.
Why Buspirone is Different
Buspirone works through a completely different mechanism than benzodiazepines:
- It acts as a partial agonist at serotonin 5-HT1A receptors
- It does NOT act on GABA-A receptors (the mechanism responsible for benzodiazepine dependence)
- It does not produce physical dependence, tolerance, or withdrawal symptoms
The FDA labeling for buspirone contains no warnings or recommendations regarding tapering 2. This contrasts sharply with benzodiazepines, where the FDA explicitly warns about withdrawal risks.
Clinical Considerations
While tapering is not medically necessary for buspirone, you should still:
- Monitor for return of anxiety symptoms after discontinuation, which represents the underlying condition re-emerging, not withdrawal
- Consider the clinical context: if buspirone was effective, stopping it may lead to symptom recurrence within days to weeks
- Distinguish between withdrawal (which doesn't occur with buspirone) and symptom relapse (which can occur with any effective anxiolytic)
Common Pitfall to Avoid
Do not confuse buspirone with benzodiazepines. The general guideline recommendation to "taper medication slowly to avoid withdrawal symptoms (e.g., benzodiazepines or SSRIs)" 3 explicitly lists benzodiazepines as examples requiring tapering—buspirone is not mentioned because it doesn't require this approach.
The extensive literature on benzodiazepine tapering using hyperbolic dose reductions 4, 5, 6 is completely irrelevant to buspirone discontinuation, as these medications have entirely different pharmacological profiles and dependence risks.